Press Releases

June 2, 2008

Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions

February 25, 2008

MacuSight™ Announces Positive Preliminary Results from Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration

February 20, 2008

MacuSight™ Expands Management Team with Appointment of Dr. Joel Naor as Chief Medical Officer

October 1, 2007

MacuSight™ Announces Positive Initial Results From Phase 1 Study Of Sirolimus In Diabetic Macular Edema

April 10, 2007

MacuSight™ To Present At IBC’s 4th International Conference On Ocular Anti-Angiogenesis

November 2, 2006

MacuSight™ Appoints Brian C. Cunningham to Board of Directors

October 31, 2006

MacuSight™ Initiates Wet Age-Related Macular Degeneration Study

September 26, 2006

MacuSight™ Initiates First Phase 1 Study of Novel Ophthalmic Drug Candidate

August 8, 2006

MacuSight™ Announces FDA Acceptance of IND for Novel Ophthalmic Drug Candidate

• Investors & Media
• Press Releases
• Financing Overview
• Contacts